G. Amari

发表

Erythroid differentiation ability of butyric acid analogues: identification of basal chemical structures of new inducers of foetal haemoglobin.

R. Gambari, M. Borgatti, I. Lampronti, 2015, European journal of pharmacology.

Structural characterization and solution rotational isomerism of delapril hydrochloride, a dipeptide angiotensin-converting enzyme inhibitor

A. Bacchi, P. Ventura, M. Zanol, 1998 .

Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.

E. Galbiati, M. Civelli, P. Caruso, 2002, The Journal of pharmacology and experimental therapeutics.

Pharmacological Actions of a Novel, Potent, Tissue-Selective Benzopyran Estrogen

E. Galbiati, M. Civelli, P. Caruso, 2002, Journal of Pharmacology and Experimental Therapeutics.

Synthesis of glycose carbamides and evaluation of the induction of erythroid differentiation of human erythroleukemic K562 cells.

R. Gambari, N. Bianchi, F. D’Andrea, 2009, European journal of medicinal chemistry.

CHF6001 I: A Novel Highly Potent and Selective Phosphodiesterase 4 Inhibitor with Robust Anti-Inflammatory Activity and Suitable for Topical Pulmonary Administration

E. Hirsch, A. Sala, G. Villetti, 2015, The Journal of Pharmacology and Experimental Therapeutics.

New method for the resolution of the enantiomers of 5,6-dihydroxy-2-methyl-aminotetralin by selective derivatization and HPLC analysis: application to biological fluids.

P. Ventura, I. Rondelli, G. Amari, 1996, Chirality.

Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).

B. Imbimbo, G. Villetti, G. Dondio, 2007, Journal of medicinal chemistry.

Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.

M. Mor, E. Galbiati, M. Civelli, 2004, Bioorganic & medicinal chemistry.

The Molecular Structure and Crystal Organization Of Rac -terfenadine/β-cyclodextrin/tartaric Acid Multicomponent Inclusion Complex

G. Sheldrick, A. Bacchi, G. Pelizzi, 2002 .

The Crystal Structure of the Inclusion Complex of the Sodium Salt of Piroxicam with β-cyclodextrin

P. Ventura, C. Rizzoli, A. Chiesi-Villa, 1998 .

Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).

C. Bigogno, B. Imbimbo, G. Villetti, 2007, Journal of medicinal chemistry.

Differentiation of diastereomeric aminotetralins by metastable ion spectra of 2-oxazolidinone derivatives upon electron-impact ionization

P. Ventura, A. Selva, G. Amari, 1992 .

Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist

M. Zaniboni, G. Rossoni, G. Villetti, 2010, Journal of Pharmacology and Experimental Therapeutics.

Microsoft Word - 1192223-file00

M. Zaniboni, M. Civelli, F. Pastore, 2010 .

Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.

A. Capelli, P. Puccini, G. Villetti, 2023, Journal of medicinal chemistry.

Novel Basic Isoflavones as Inhibitors of Bone Resorption

P. Carrupt, B. Testa, E. Galbiati, 2001 .

Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.

S. Catinella, Valentina Bagnacani, F. Amadei, 2017, Journal of medicinal chemistry.

Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.

S. Catinella, F. Amadei, P. Puccini, 2014, Journal of medicinal chemistry.

Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).

M. Racchi, C. Bartolucci, G. Villetti, 2006, Journal of medicinal chemistry.

Solution- and solid-state structures of the (-)-n-heptylcarbamate of geneseroline and its hydrochloride salt.

A. Bacchi, P. Ventura, G. Pelizzi, 1995, Journal of pharmaceutical sciences.

CHF6001 I: A Novel Highly Potent and Selective Phosphodiesterase 4 Inhibitor with Robust Anti-Inflammatory Activity and Suitable for Topical Pulmonary Administration

E. Hirsch, A. Sala, G. Villetti, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.

F. Amadei, P. Puccini, G. Villetti, 2023, Journal of medicinal chemistry.

Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease.

F. Amadei, P. Puccini, G. Villetti, 2021, Journal of medicinal chemistry.

Synthesis of glycose carbamides and evaluation of the induction of erythroid differentiation of human erythroleukemic K562 cells.

R. Gambari, N. Bianchi, F. D’Andrea, 2009, European journal of medicinal chemistry.